Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.
Stark AR, Carlo WA, Vohr BR, Papile LA, Saha S, Bauer CR, Oh W, Shankaran S, Tyson JE, Wright LL, Poole WK, Das A, Stoll BJ, Fanaroff AA, Korones SB, Ehrenkranz RA, Stevenson DK, Peralta-Carcelen M, Wilson-Costello DE, Bada HS, Heyne RJ, Johnson YR, Lee KG, Steichen JJ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.
Stark AR, et al.
J Pediatr. 2014 Jan;164(1):34-39.e2. doi: 10.1016/j.jpeds.2013.07.027. Epub 2013 Aug 27.
J Pediatr. 2014.
PMID: 23992673
Free PMC article.